“School of Cognitive”

Back to Papers Home
Back to Papers of School of Cognitive

Paper   IPM / Cognitive / 11297
School of Cognitive Sciences
  Title:   Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats
  Author(s): 
1.  Mohammad Nasehi
2.  Mousa Sahebgharani
3.  Ali Haeri-Rohani
4.  Mohammad Reza Zarrindast
  Status:   Published
  Journal: Neurobiology of Learning and Memory
  Vol.:  92
  Year:  2009
  Pages:   391-399
  Supported by:  IPM
  Abstract:
In the present study, the effects of intra-dorsal hippocampus (intra-CA1) injection of cannabinoid receptor agents on memory formation have been investigated in 3-days apomorphine-treated rats. Stepthrough inhibitory avoidance task of memory has been used to examine retrieval of memory formation, 24 h after training. Apomorphine was injected subcutaneously (S.C.), once daily for 3-days followed by 5 days free of the apomorphine before training. Bilateral post-training intra-CA1 infusions of the non selective CB1?CB2 receptor agonist, WIN55, 212?2 (0.1, 0.25 and 0.5 ug/rat), dose-dependently shortened the step-through latency, suggesting amnesia by the drug, whereas bilateral post-training intra-CA1 micro-injections of the selective CB1 receptor antagonist, AM251 (25, 50 and 100 ug/rat), did not affect memory formation. Intra-CA1 infusions of AM251 and WIN55, 212?2, two min apart, modify the WIN55,212?2-induced reduction of step-through latency. Furthermore, the deleterious effect of WIN55, 212?2 (0.25 ug/rat) was completely abolished in rats previously given apomorphine (0.5 and 1 mg/kg/day, S.C.) for 3 days. This prevention of WIN55,212?2-induced amnestic-like effect was counteracted by the dopamine D2 receptor antagonist, sulpiride (0.25, 0.5 and 1 mg/kg/day * 3-days, S.C.), administered 30 min before each injection of apomorphine (0.5 mg/kg/day * 3-days, S.C.). The D1 receptor antagonist, SCH 23390 (0.01, 0.02, 0.07 and 0.1 mg/kg/day * 3-days, S.C.), was ineffective in this respect. The results suggest that subchronic apomorphine treatment may induce dopamine D2 receptor sensitization, which in turn prevented amnesia induced by WIN55, 212?2.

Download TeX format
back to top
scroll left or right